Healthcare & Pharmaceuticals Industry Press Releases

Healthcare & Pharmaceuticals Industry Press Releases Distributed by EIN Presswire

85,030 Press Releases · RSS · Email

Published on December 11, 2018 - 13:05 GMT

Aravive Biologics Initiates Phase 1b Portion of Phase 1b/2 Clinical Trial of AVB-S6-500 in Platinum-Resistant Recurrent Ovarian ...

HOUSTON, Dec. 11, 2018 (GLOBE NEWSWIRE) -- Aravive, Inc. (Nasdaq: ARAV), a clinical-stage biopharmaceutical company, today announced that the company has begun treating patients in the Phase 1b portion of a Phase 1b/Phase 2 trial combining AVB-S6-500 with …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on December 11, 2018 - 13:00 GMT

Rafael Pharmaceuticals Announces Initiation of Pivotal Phase 3 Trial (AVENGER 500) of CPI-613 (devimistat) in Combination with ...

Newark, NJ, Dec. 11, 2018 (GLOBE NEWSWIRE) -- Rafael Pharmaceuticals, Inc. (Rafael), a leader in the growing field of cancer metabolism-based therapeutics, today announced the initiation of a phase 3 multicenter, open-label, randomized pivotal trial ( …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on December 11, 2018 - 13:00 GMT

Operation Hat Trick Donates $10,000 to SoldierStrong

STAMFORD, Conn. and HAMPTON, N.H., Dec. 11, 2018 (GLOBE NEWSWIRE) -- SoldierStrong, a nonprofit organization dedicated to providing advanced medical technologies to veterans, has received a donation of $10,000 from Operation Hat Trick, which generates …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on December 11, 2018 - 13:00 GMT

Comfort Launch by Vergence Naturals Exceeds Expectations

VANCOUVER, British Columbia, Dec. 11, 2018 (GLOBE NEWSWIRE) -- Abattis Bioceuticals Corp. (the “Company” or “Abattis”) (CSE:ATT) (OTC:ATTBF) is pleased to provide an update on the recent soft-launch of its cannabinoid-infused nutraceutical Comfort (“ …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on December 11, 2018 - 13:00 GMT

HealthLynked to Attend the 2019 HIMSS Global Conference & Exhibition

NAPLES, Fla., Dec. 11, 2018 (GLOBE NEWSWIRE) -- HealthLynked Corp. (OTCQB: HLYK) today announced that the Company will be attending the HIMSS Global Conference & Exhibition (Healthcare Information and Management Systems Society) taking place on …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on December 11, 2018 - 13:00 GMT

Marijuana Company of America Announces New hempSMART™ Website and Sales Platform

ESCONDIDO, Calif., Dec. 11, 2018 (GLOBE NEWSWIRE) -- via NetworkWire -- MARIJUANA COMPANY OF AMERICA INC. (“MCOA” or the “Company”) (OTC: MCOA), an innovative hemp and cannabis corporation, is pleased to announce the launch of a new corporate hempSMART™ …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...
Published on December 11, 2018 - 12:45 GMT

T1D Exchange Names New Board Members

David Walton, MBA Mr. Walton is the Founder and CEO of Pennsylvania-based Chronicare, a digital health company utilizing connected monitoring solutions to improve medication adherence and outcomes in people with diabetes and other chronic diseases. He …

Distribution channels: Banking, Finance & Investment Industry, Healthcare & Pharmaceuticals Industry ...
Published on December 11, 2018 - 12:35 GMT

Intensity Therapeutics Strengthens Intellectual Property Portfolio with Issuance of Several New Patents in Asia and Australia

WESTPORT, Conn., Dec. 11, 2018 (GLOBE NEWSWIRE) -- Intensity Therapeutics, Inc., a clinical-stage biotechnology company developing proprietary technology and products to kill tumors and increase immune cell recognition of solid tumor cancers, today …

Distribution channels: Healthcare & Pharmaceuticals Industry, Law ...
Published on December 11, 2018 - 12:30 GMT

REMINDER: Moleculin Announces Conference Call to Discuss Recent Breakthrough Discovery and FDA Filing on Wednesday, December 12, ...

HOUSTON, Dec. 11, 2018 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc., (Nasdaq: MBRX) ("Moleculin" or the "Company"), a clinical stage pharmaceutical company focused on the development of oncology drug candidates, all of which are based …

Distribution channels: Conferences & Trade Fairs, Healthcare & Pharmaceuticals Industry ...
Published on December 11, 2018 - 12:30 GMT

Kiniksa Announces Rilonacept Interim Phase 2 Clinical Data and Initiates Pivotal Phase 3 Clinical Trial

- Phase 2 enrollment completed; interim clinical data show reductions in both inflammation and reported pain after first dose and throughout treatment period - Pivotal Phase 3 clinical trial, RHAPSODY, now actively recruiting and screening subjects …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on December 11, 2018 - 12:30 GMT

SunGen Pharma Receives Its Second and Third ANDA Approval from US FDA

PRINCETON, N.J., Dec. 11, 2018 (GLOBE NEWSWIRE) -- SunGen Pharma, a privately held specialty pharmaceutical company which develops, contract manufactures, and sells pharmaceutical finished products, today announced it has received its second and third …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on December 11, 2018 - 12:05 GMT

Helius Medical Technologies, Inc. Announces Exercise of Underwriters’ Overallotment Option

NEWTOWN, Pa., Dec. 11, 2018 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) (“Helius” or the “Company”) announced today that the underwriters of its previously announced public offering of 2,121,212 shares of Class A common …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on December 11, 2018 - 12:00 GMT

Optinose Announces Update to License Agreement with Avanir Pharmaceuticals for ONZETRA XSAIL

YARDLEY, Pa., Dec. 11, 2018 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced the Company received written notice from Avanir …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on December 11, 2018 - 12:00 GMT

Athenex Announces Positive Second Cohort Results of Oraxol-plus-Ramucirumab Phase 1b Clinical Trial in Gastric Cancer

BUFFALO, N.Y., Dec. 11, 2018 (GLOBE NEWSWIRE) -- Athenex, Inc., a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies for the treatment of cancer, today announced that its global Phase 1b …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on December 11, 2018 - 12:00 GMT

Intra-Cellular Therapies Announces FDA Acceptance of New Drug Application for Lumateperone for the Treatment of Schizophrenia

NEW YORK, Dec. 11, 2018 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq: ITCI), a biopharmaceutical company focused on the development of therapeutics for central nervous system (CNS) disorders, today announced that the U.S. Food and Drug …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on December 11, 2018 - 12:00 GMT

CHMP Extends Review Period for Portola Pharmaceuticals’ Ondexxya™ (andexanet alfa)

SOUTH SAN FRANCISCO, Calif., Dec. 11, 2018 (GLOBE NEWSWIRE) -- Portola Pharmaceuticals, Inc.® (Nasdaq: PTLA) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has extended the review …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on December 11, 2018 - 11:35 GMT

RACE TO REDUCE JOINT PAINHEATS UP

Hot Springs Village, AR, Dec. 11, 2018 (GLOBE NEWSWIRE) -- As Americans continue to lose faith in glucosamine to reduce joint pain, the number-one selling joint-health product in Holland has entered the U.S. market. Derived from green-lipped mussels …

Distribution channels: Culture, Society & Lifestyle, Food & Beverage Industry ...
Published on December 11, 2018 - 10:59 GMT

Nearly 1 million children in West Nile to benefit from better quality health services

With new funding from the Swedish International Development Agency (Sida), nearly one million children in West Nile, including newborns and adolescents, together with pregnant women, will soon benefit from better quality health services. “Supporting …

Distribution channels: Business & Economy, Culture, Society & Lifestyle ...
Published on December 10, 2018 - 21:59 GMT

Dr. Michael Hart’s Book Explores the Benefits of Cannabis for Treating PTSD In Veterans

Dr. Michael Hart, a physician and author based in London, Ontario, has announced the release of his latest book LONDON, ONTARIO, CANADA, December 10, 2018 /⁨EINPresswire.com⁩/ -- Dr. Michael Hart, a physician and author based in London, Ontario, has …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on December 11, 2018 - 07:00 GMT

3rd Quarter Results

Summit Therapeutics plc (‘Summit’, the ‘Company’ or the ‘Group’) Summit Therapeutics Reports Financial Results for the Third Quarter and Nine Months Ended 31 October 2018 and Operational Progress Continued Momentum in Building a Portfolio of …

Distribution channels: Banking, Finance & Investment Industry, Healthcare & Pharmaceuticals Industry ...

1 2 3 4 5 6 7 8 9 10 11 Next

Healthcare & Pharmaceuticals Industry Press Releases

Healthcare & Pharmaceuticals Industry Press Releases Distributed by EIN Presswire

Browse by Topic